Spider venom-based drug enters trials for heart attacks, strokes

The current phase 1 clinical study will assess the safety, tolerability and dosage of IB409, a novel drug developed from a molecule found in Australian funnel-web spider venom by biotechnology company Infensa Bioscience, said a…